PerpEquities

Equity · Healthcare

BeOne Medicines AG (STAR Market shares) (BEIGENE) perpetual futures

BEIGENE perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade BEIGENEUSDT.

BeOne Medicines AG (STAR Market shares) tracked across crypto venues with normalized contract specifications.

$38.67-3.2%
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · Gate.io (BEIGENE/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$168
Open interest
$425.4
Best liquidity
$0
Gate.io
Tightest spread
+225.1 bps
Gate.io
Highest volume
$168
Gate.io
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $85M
OI / float
0.00%
Float $34.1B
Spot performance
1D-3.19%
5D+0.39%
1M-6.75%
6M+16.68%
YTD-3.95%
1Y-16.69%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
Gate.ioTradeBEIGENE/USDTTrading$38.670.0% APR
0.000% every 8h
+225.1 bps$0$168$425.4USDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 1 venues absorb $10k

No fresh book data: Gate.io

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

BEIGENE

Tightest spread

BEIGENE

Highest volume

BEIGENE

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 1h ago
Market cap
$40.1B
Updated 1h ago
Revenue
$6.2B
Trailing 12 months
Revenue growth
+23%
Next fiscal year
Profit margin
+10.7%
P/E
25.7
Peer P/E 19.7
Free cash flow
$1.3B
Trailing 12 months
More metrics
Net income
$658M
Trailing 12 months
P/S
6.5
Peer P/E
19.7
Similar listed perps
Revenue estimate
$6.7B
Next fiscal year
Earnings
2026-11-05
Revenue est. $1.7B · Updated 1h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$5.5B
Net margin+5.4%
Free cash flow$861.1M
Net debt-$3.5B
2020$308.9M
2021$1.2B
2022$1.4B
2023$2.5B
2024$3.8B
2025$5.5B
PeriodRevenueGrowthNet incomeFCF
2020$308.9M-28%-$1.6B-$1.5B
2021$1.2B+281%-$1.5B-$1.6B
2022$1.4B+20%-$2B-$2B
2023$2.5B+74%-$881.7M-$1.8B
2024$3.8B+55%-$644.8M-$669.8M
2025$5.5B+44%$294.9M$861.1M
PeriodGross marginOperating marginNet marginROEROA
2020-342.1%-536.7%-526.1%-42.0%-29.0%
2021+86.0%-122.3%-123.9%-23.4%-16.9%
2022+79.8%-126.4%-141.5%-45.7%-31.4%
2023+84.5%-49.1%-35.9%-24.9%-15.2%
2024+84.4%-14.9%-16.9%-19.4%-10.9%
2025+85.3%+8.4%+5.4%+6.8%+3.6%
PeriodCashDebtNet debtCurrent ratio
2020$1.4B$562M-$820M4.61
2021$4.4B$694.6M-$3.7B4.76
2022$3.9B$596.7M-$3.3B3.55
2023$3.2B$930.2M-$2.2B2.32
2024$2.6B$1.1B-$1.5B1.80
2025$4.6B$1.1B-$3.5B3.41
PeriodMarket capEnterprise valueP/SP/E
2020$2.1B$1.2B6.7-1.3
2021$2.1B-$1.6B1.8-1.4
2022$2B-$1.3B1.4-1.0
2023$2B-$191.8M0.8-2.3
2024$2.3B$774.4M0.6-3.6
2025$54.4B$51B9.9182.9
Q3 2024$1B
Q4 2024$1.2B
Q1 2025$1.1B
Q2 2025$1.3B
Q3 2025$1.4B
Q4 2025$1.5B
Q1 2026$1.5B
Q2 2026$1.7B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$1B+45%-$154M$54.7M
Q4 2024$1.2B+85%-$139.7M-$17.3M
Q1 2025$1.1B+49%$1.3M-$72.3M
Q2 2025$1.3B+42%$94.3M$199.8M
Q3 2025$1.4B+35%$124.8M$354.5M
Q4 2025$1.5B+28%$67.4M$387.7M
Q1 2026$1.5B+36%$228.7M$160.5M
Q2 2026$1.7B+30%$237M$414.8M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+83.3%-11.2%-14.7%-4.5%-2.6%
Q4 2024+85.4%-8.5%-11.8%-4.2%-2.4%
Q1 2025+85.2%+1.0%+0.1%0.0%0.0%
Q2 2025+87.5%+6.7%+7.2%+2.5%+1.5%
Q3 2025+86.1%+11.5%+8.8%+3.0%+1.6%
Q4 2025+88.4%+12.4%+4.4%+1.5%+0.8%
Q1 2026+86.6%+16.5%+15.0%+4.8%+2.7%
Q2 2026+89.8%+19.1%+13.9%+4.6%+2.6%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$2.7B$1.1B-$1.6B1.93
Q4 2024$2.6B$1.1B-$1.5B1.80
Q1 2025$2.5B$996.8M-$1.5B1.96
Q2 2025$2.8B$1B-$1.7B1.95
Q3 2025$4B$1B-$3B2.39
Q4 2025$4.6B$2B-$2.6B3.41
Q1 2026$4.9B$2.1B-$2.8B3.64
Q2 2026$5.1B$1.1B-$4B3.40
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$2.7B$1.1B2.6-4.4
Q4 2024$2.3B$795.8M2.0-4.2
Q1 2025$3.7B$2.1B3.3721.5
Q2 2025$3.5B$1.8B2.61.2
Q3 2025$4.8B$1.7B3.49.5
Q4 2025$55.3B$52.7B36.4203.4
Q1 2026$48.8B$46B32.152.9
Q2 2026$54.4B$50.4B31.958.6

Refreshed 1h ago

Charts: revenue, profit, cash flow & valuation
Revenue$1.7BQ2 2026
$426.3M$852.5M$1.3B$1.7BQ3 2023: $721.1MQ4 2023: $643MQ1 2024: $751.7MQ2 2024: $929.2MQ3 2024: $1BQ4 2024: $1.2BQ1 2025: $1.1BQ2 2025: $1.3BQ3 2025: $1.4BQ4 2025: $1.5BQ1 2026: $1.5BQ2 2026: $1.7BQ3 2023Q2 2026
Net income$237MQ2 2026
-$191.8M-$48.9M$94.1M$237MQ3 2023: $198MQ4 2023: -$334.8MQ1 2024: -$251.2MQ2 2024: -$120.4MQ3 2024: -$154MQ4 2024: -$139.7MQ1 2025: $1.3MQ2 2025: $94.3MQ3 2025: $124.8MQ4 2025: $67.4MQ1 2026: $228.7MQ2 2026: $237MQ3 2023Q2 2026
EBITDA$392.7MQ2 2026
-$170.9M$17M$204.8M$392.7MQ3 2023: -$93.2MQ4 2023: -$358.7MQ1 2024: -$219.3MQ2 2024: -$82.2MQ3 2024: -$121.7MQ4 2024: -$33.3MQ1 2025: $52.5MQ2 2025: $135.2MQ3 2025: $163.1MQ4 2025: $208.6MQ1 2026: $335.3MQ2 2026: $392.7MQ3 2023Q2 2026
Free cash flow$414.8MQ2 2026
-$272.5M-$43.4M$185.7M$414.8MQ3 2023: -$260.4MQ4 2023: -$388.5MQ1 2024: -$501.6MQ2 2024: -$205.5MQ3 2024: $54.7MQ4 2024: -$17.3MQ1 2025: -$72.3MQ2 2025: $199.8MQ3 2025: $354.5MQ4 2025: $387.7MQ1 2026: $160.5MQ2 2026: $414.8MQ3 2023Q2 2026
EPS$0.16Q2 2026
-$0.8$1.61$4.03$6.45Q3 2023: $1.88Q4 2023: -$3.22Q1 2024: -$2.47Q2 2024: -$1.15Q3 2024: -$1.47Q4 2024: -$1.31Q1 2025: $0.01Q2 2025: $6.45Q3 2025: $1.09Q4 2025: $0.04Q1 2026: $0.15Q2 2026: $0.16Q3 2023Q2 2026
Cash / Debt$5.1BQ2 2026
$1.3B$2.5B$3.8B$5.1BQ3 2023 · Cash: $3.1BQ3 2023 · Debt: $579.8MQ4 2023 · Cash: $3.2BQ4 2023 · Debt: $930.2MQ1 2024 · Cash: $2.8BQ1 2024 · Debt: $1.1BQ2 2024 · Cash: $2.6BQ2 2024 · Debt: $1.1BQ3 2024 · Cash: $2.7BQ3 2024 · Debt: $1.1BQ4 2024 · Cash: $2.6BQ4 2024 · Debt: $1.1BQ1 2025 · Cash: $2.5BQ1 2025 · Debt: $996.8MQ2 2025 · Cash: $2.8BQ2 2025 · Debt: $1BQ3 2025 · Cash: $4BQ3 2025 · Debt: $1BQ4 2025 · Cash: $4.6BQ4 2025 · Debt: $2BQ1 2026 · Cash: $4.9BQ1 2026 · Debt: $2.1BQ2 2026 · Cash: $5.1BQ2 2026 · Debt: $1.1BQ3 2023Q2 2026
CashDebt
Profitability+89.8%Q2 2026
-16.7%+18.8%+54.3%+89.8%Q3 2023 · Gross margin: +88.5%Q4 2023 · Gross margin: +82.6%Q1 2024 · Gross margin: +83.4%Q2 2024 · Gross margin: +85.1%Q3 2024 · Gross margin: +83.3%Q4 2024 · Gross margin: +85.4%Q1 2025 · Gross margin: +85.2%Q2 2025 · Gross margin: +87.5%Q3 2025 · Gross margin: +86.1%Q4 2025 · Gross margin: +88.4%Q1 2026 · Gross margin: +86.6%Q2 2026 · Gross margin: +89.8%Q3 2023 · Operating margin: -21.9%Q4 2023 · Operating margin: -52.1%Q1 2024 · Operating margin: -34.8%Q2 2024 · Operating margin: -11.5%Q3 2024 · Operating margin: -11.2%Q4 2024 · Operating margin: -8.5%Q1 2025 · Operating margin: +1.0%Q2 2025 · Operating margin: +6.7%Q3 2025 · Operating margin: +11.5%Q4 2025 · Operating margin: +12.4%Q1 2026 · Operating margin: +16.5%Q2 2026 · Operating margin: +19.1%Q3 2023 · Net margin: +27.5%Q4 2023 · Net margin: -52.1%Q1 2024 · Net margin: -33.4%Q2 2024 · Net margin: -13.0%Q3 2024 · Net margin: -14.7%Q4 2024 · Net margin: -11.8%Q1 2025 · Net margin: +0.1%Q2 2025 · Net margin: +7.2%Q3 2025 · Net margin: +8.8%Q4 2025 · Net margin: +4.4%Q1 2026 · Net margin: +15.0%Q2 2026 · Net margin: +13.9%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+29.6%Q2 2026
+21.2%+42.4%+63.6%+84.8%Q3 2024: +45.2%Q4 2024: +84.8%Q1 2025: +48.6%Q2 2025: +41.6%Q3 2025: +34.9%Q4 2025: +27.8%Q1 2026: +36.3%Q2 2026: +29.6%Q3 2023Q2 2026
Shares outstanding1.5BQ2 2026
376.3M752.7M1.1B1.5BQ3 2023: 105.2MQ4 2023: 104.1MQ1 2024: 104.3MQ2 2024: 104.7MQ3 2024: 105MQ4 2024: 106.3MQ1 2025: 111.2MQ2 2025: 109MQ3 2025: 114.5MQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2023Q2 2026
Valuation58.6Q2 2026
177.1358.6540.1721.5Q3 2023 · P/E: 2.6Q4 2023 · P/E: -1.5Q1 2024 · P/E: -1.9Q2 2024 · P/E: -3.4Q3 2024 · P/E: -4.4Q4 2024 · P/E: -4.2Q1 2025 · P/E: 721.5Q2 2025 · P/E: 1.2Q3 2025 · P/E: 9.5Q4 2025 · P/E: 203.4Q1 2026 · P/E: 52.9Q2 2026 · P/E: 58.6Q3 2023 · P/S: 2.8Q4 2023 · P/S: 3.2Q1 2024 · P/S: 2.4Q2 2024 · P/S: 1.8Q3 2024 · P/S: 2.6Q4 2024 · P/S: 2.0Q1 2025 · P/S: 3.3Q2 2025 · P/S: 2.6Q3 2025 · P/S: 3.4Q4 2025 · P/S: 36.4Q1 2026 · P/S: 32.1Q2 2026 · P/S: 31.9Q3 2023Q2 2026
P/EP/S
Revenue$5.5B2025
$1.4B$2.7B$4.1B$5.5B2018: $198.2M2019: $428.2M2020: $308.9M2021: $1.2B2022: $1.4B2023: $2.5B2024: $3.8B2025: $5.5B20182025
Net income$294.9M2025
-$1.4B-$854.5M-$279.8M$294.9M2018: -$673.8M2019: -$948.6M2020: -$1.6B2021: -$1.5B2022: -$2B2023: -$881.7M2024: -$644.8M2025: $294.9M20182025
EBITDA$633.8M2025
-$1.3B-$632.1M$879.7K$633.8M2018: -$695.4M2019: -$941.3M2020: -$1.6B2021: -$1.4B2022: -$1.9B2023: -$1.1B2024: -$402M2025: $633.8M20182025
Free cash flow$861.1M2025
-$1.3B-$552.3M$154.4M$861.1M2018: -$688.6M2019: -$908.9M2020: -$1.5B2021: -$1.6B2022: -$2B2023: -$1.8B2024: -$669.8M2025: $861.1M20182025
EPS$0.22025
-$14.6-$9.64-$4.72$0.22018: -$12.22019: -$15.82020: -$19.52021: -$15.72022: -$19.42023: -$8.452024: -$6.122025: $0.220182025
Cash / Debt$4.6B2025
$1.1B$2.3B$3.4B$4.6B2018 · Cash: $712.9M2018 · Debt: $198.4M2019 · Cash: $618M2019 · Debt: $277.3M2020 · Cash: $1.4B2020 · Debt: $562M2021 · Cash: $4.4B2021 · Debt: $694.6M2022 · Cash: $3.9B2022 · Debt: $596.7M2023 · Cash: $3.2B2023 · Debt: $930.2M2024 · Cash: $2.6B2024 · Debt: $1.1B2025 · Cash: $4.6B2025 · Debt: $1.1B20182025
CashDebt
Profitability+85.3%2025
-381.0%-225.4%-69.7%+86.0%2018 · Gross margin: -257.0%2019 · Gross margin: -133.2%2020 · Gross margin: -342.1%2021 · Gross margin: +86.0%2022 · Gross margin: +79.8%2023 · Gross margin: +84.5%2024 · Gross margin: +84.4%2025 · Gross margin: +85.3%2018 · Operating margin: -356.1%2019 · Operating margin: -224.2%2020 · Operating margin: -536.7%2021 · Operating margin: -122.3%2022 · Operating margin: -126.4%2023 · Operating margin: -49.1%2024 · Operating margin: -14.9%2025 · Operating margin: +8.4%2018 · Net margin: -339.9%2019 · Net margin: -221.5%2020 · Net margin: -526.1%2021 · Net margin: -123.9%2022 · Net margin: -141.5%2023 · Net margin: -35.9%2024 · Net margin: -16.9%2025 · Net margin: +5.4%20182025
Gross marginOperating marginNet margin
Revenue growth+44.1%2025
+49.3%+126.5%+203.7%+280.8%2019: +116.0%2020: -27.9%2021: +280.8%2022: +20.4%2023: +73.7%2024: +55.0%2025: +44.1%20182025
Shares outstanding1.5B2025
368.7M737.4M1.1B1.5B2018: 55.4M2019: 60.1M2020: 83.5M2021: 92.8M2022: 103.1M2023: 104.4M2024: 105.3M2025: 1.5B20182025
Valuation182.92025
43.089.6136.2182.92018 · P/E: -1.92019 · P/E: -1.52020 · P/E: -1.32021 · P/E: -1.42022 · P/E: -1.02023 · P/E: -2.32024 · P/E: -3.62025 · P/E: 182.92018 · P/S: 6.52019 · P/S: 3.22020 · P/S: 6.72021 · P/S: 1.82022 · P/S: 1.42023 · P/S: 0.82024 · P/S: 0.62025 · P/S: 9.920182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-11-05
Revenue est. $1.7B · Updated 1h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20260.56$6.7B+23%6
FY 20270.77$7.8B+42%6
FY 20281.05$8.9B+62%3
FY 20291.23$9.8B+78%3
FY 20301.51$11.1B+102%2
Q1 20270.15$1.8B+15%1

Company events

6
2026-11-05EarningsActual - / Estimate 0.98-
2026-08-05EarningsActual 1.06 / Estimate 0.86Beat
2026-05-06EarningsActual 1.02 / Estimate 0.56Beat
2026-02-26EarningsActual 0.33 / Estimate 0.67Miss
2025-11-06EarningsActual 0.65 / Estimate 0.54Beat
2025-08-05EarningsActual 0.55 / Estimate 0.21Beat

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering BEIGENE have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings00
Analysts00
Buy / hold / sell
Upgrades / downgrades / initiations0 / 0 / 00 / 0 / 0
Price targets hit / missed
Avg. return after a rating (TipRanks)
Best / worst call / /

After buy calls on this stock: not enough measured cases yet

TipRanks data via FMP · computed Sep 24, 2026 · 0 ratings

Frequently asked questions

Where can I trade BEIGENE perpetual futures?

BeOne Medicines AG (STAR Market shares) (BEIGENE) perpetual futures trade on 1 crypto venues, including Gate.io. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade BEIGENE around the clock?

Yes. Unlike the underlying stock, BEIGENE perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on BEIGENE perpetuals?

Right now the BEIGENE perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to 0.0% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the BEIGENE perp price compare to the BeOne Medicines AG (STAR Market shares) stock?

The venue-median BEIGENE perp mark is $38.7 versus a reference stock price of $38.7, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a BEIGENE perpetual future?

A BEIGENE perpetual is a derivative that tracks the price of BeOne Medicines AG (STAR Market shares) with no expiry date. It lets you take long or short exposure to BeOne Medicines AG (STAR Market shares) on crypto venues, around the clock.

What is BEIGENEUSDT perpetual?

BEIGENEUSDT is the symbol most crypto exchanges use for the BeOne Medicines AG (STAR Market shares) perpetual settled in USDT (Tether). It tracks the BEIGENE share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

BEIGENE perpetuals · perpequities.comBEIGENE perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/beigene-perp"><img src="https://perpequities.com/badge/beigene-perp.svg" width="240" height="64" alt="BEIGENE perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of BEIGENE perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for BEIGENE — one email every Sunday.

Watchlist and alerts

Price and funding alerts for BEIGENE, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X